PAO9- IS RESIDRONATE MORE COST-EFFECTIVE THAN ETIDRONATE FOR FRACTURE PREVENTION? A COST-UTILITY ANALYSIS
Sep 1, 2000, 00:00
10.1016/S1098-3015(11)70723-9
https://www.valueinhealthjournal.com/article/S1098-3015(11)70723-9/fulltext
Title :
PAO9- IS RESIDRONATE MORE COST-EFFECTIVE THAN ETIDRONATE FOR FRACTURE PREVENTION? A COST-UTILITY ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70723-9&doi=10.1016/S1098-3015(11)70723-9
First page :
Section Title :
Open access? :
No
Section Order :
107